Defense Supply Center Philadelphia, Attn: DSCP-M Bldg 6, 700 Robbins Ave., Philadelphia, PA 19111

65 -- RECOMBINANT DNA (RDNA) HUMAN INSULIN SOL SP0200-99-R-1506 DUE 062499 POC Stephen Lewis, Contract Specialist (215) 737-5649 and Linda Magazu, Contracting Officer (215) 737-2622 WEB: DSCP Home page, http://www.dscp.dla.mil. E-MAIL: Email addressis the contracting officer, Linda Magazu, The agency POC is lmagazu@dscp.dla.mil or slewis@dscp.dla.mil. This is an amended CBD for (rDNA) Human Insulin Cite (W-013 SN287746) 1. Pharmaceutical companies are invited, but not required, to make a pre-solicitation presentation about patient and staff diabetes educational activities and materials customarily offered in support of their Recombinant DNA (rDNA) Human Insulin Products. Presentations at the DoD Pharmacoeconomic Center may take place between 17 May 1999 and 21 May 1999. One presentation will be permitted for each manufacturer. Each presentation will be limited to no more than one hour. Companies may schedule their presentations by contacting MAJ Donald DeGroff at the DoD Pharmacoeconomic Center, telephone 210-295-9635 or 210-295-1271. Pharmaceutical companies are encouraged to provide the following information concerning their educational activities and materials and Recombinant DNA (rDNA) Human Insulin formulations of 70/30, N, R and L in 10 ml sterile multi-use vials/bottles with a strength of 100u/ml: a. A listing and copy of educational materials and support customarily provided by a company in support of their (rDNA) Human Insulin Products. b. Information regarding the cost of switching patients from one company's product(s) to another. If costs are indentified, what are the costs related to and what is the cost per patient for DoD and VA? c. Presentation of any comparative study data on costs of switching patients from one company's (rDNA) human insulin product to another. d. Percentage of your company's human insulin sales for 70/30, N, R and L formulations to DoD and VA in the last year and yearly for the last year and yearly for the last five years. e. Ability of your company to meet DoD and VA's supply requirements. The Government may use information provided during the presentations when drafting its solicitation. However, all awards will be based on the offers received in response to the actual solicitation and the evaluation criteria set forth therin. Posted 04/30/99 (W-SN326345). (0120)

Loren Data Corp. http://www.ld.com (SYN# 0315 19990504\65-0001.SOL)